Damage or loss of brain cells and impaired neurochemistry, neurogenesis, and synaptic and
nonsynaptic plasticity of the brain lead to dementia in neurodegenerative diseases, such as …

Abstract Purpose of Review The objective of this article is to highlight the potential role of the
galantamine-memantine combination as a novel antioxidant treatment for schizophrenia …

We propose a new therapeutic strategy for Alzheimer's disease (AD). Brain peptide p3‐
Alcβ37 is generated from the neuronal protein alcadein β through cleavage of γ‐secretase …

Piracetam, a nootropic drug that has been clinically used for decades but remains enigmatic
due to no distinct understanding of its mechanism of action. The present study aimed to …

Objectives Altered amyloid metabolism and mitochondrial dysfunction play key roles in the
development of Alzheimer's disease (AD). We asked whether an association exists between …

Abstract Ethnopharmacological relevance Dementias including Alzheimer disease (AD) are
three times higher in menopausal women than in men. Phytoestrogens, a group of plant …

Remdesivir (RDV) is a novel antiviral drug whose mitochondrial effects are not well known.
In vitro effects of RDV on the mitochondrial respiration, individual respiratory complexes, and …

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a
complex pathogenesis and a common occurrence of comorbid diseases such as …

Mitochondrial complex I (NADH-dehydrogenase) and complex IV (cytochrome-c-oxidase)
are reported to be affected by drugs used to treat psychiatric or neurodegenerative diseases …

Tau protein aggregations are important contributors to the etiology of Alzheimer's disease
(AD). Hydromethylthionine (HMT) is a potent inhibitor of tau aggregation in vitro and in vivo …